Open AccessSuccessful Withdrawal of Steroids in Pediatric Renal Transplant Recipients Receiving Cyclosporine A and Mycophenolate Mofetil Treatment: Results after Four Years
Author(s) -
Britta Höcker,
Ulrike John,
Christian Plank,
Elke Wühl,
Lutz T. Weber,
Joachim Misselwitz,
Wolfgang Rascher,
Otto Mehls,
Burkhard Tönshoff
Publication year - 2004
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000133536.83756.1f
Subject(s) - mycophenolate , medicine , renal transplant , urology , transplantation
Despite their numerous systemic side effects, glucocorticoids (steroids) still form a cornerstone in immunosuppressive regimens in pediatric renal transplant recipients. The addition of mycophenolate mofetil (MMF) to a cyclosporine A (CsA)-based immunosuppressive regimen after renal transplantation may allow steroid withdrawal and amelioration or avoidance of steroid-specific side effects.